Rating History for Editas Medicine (EDIT) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for EDIT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/23/2026 Debjit Chattopadhyay Upgrade Buy
(Neutral)		 5.00
(N/A)		 2.93
(2.35)		 -19.8% Details